Quantifying risks: The case between glucocorticoids and tuberculosis

Arthritis Care and Research

Volumn 55, Issue 1, 2006, Pages 1-2

  Carmona, Loreto ^a  

^a UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

CORTICOSTEROID THERAPY; EDITORIAL; HUMAN; INCIDENCE; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; TUBERCULOSIS; VALIDATION PROCESS;

GLUCOCORTICOIDS; HUMANS; RHEUMATIC DISEASES; RISK ASSESSMENT; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 32544448688     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21703     Document Type: Editorial

References (9)

1. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
2. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006;55:19-26.
3. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-25.
4. Soriano JB, Maier WC, Visick G, Pride NB. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001;17:1075-80.
5. Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al, and the EMECAR Study Group. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003;30:1436-9.
6. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al, and the EIRA study group. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41.
7. Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9.
8. Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD, and the BIOBADASER Group. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
9. Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM, et al, and the BIOBADASER Group. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 2005;52:1766-72.